Laddar...
BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies
BRAF inhibitors vemurafenib and dabrafenib achieved improved overall survival over chemotherapy and have been approved for the treatment of BRAF-mutated metastatic melanoma. More recently, the combination of BRAF inhibitor dabrafenib with MEK inhibitor trametinib has shown improved progression-free...
Sparad:
| I publikationen: | Onco Targets Ther |
|---|---|
| Huvudupphovsmän: | , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Dove Medical Press
2015
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4303458/ https://ncbi.nlm.nih.gov/pubmed/25653539 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S39096 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|